Investigational Site Number : 7920004
Samsun 55139
0 studies enrolling now · 2 studies all time
What they study most
Multiple Sclerosis, Plasma Cell Myeloma
Studies at this site
- Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
- Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed